This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
McMullin MF, Reilly JT, Campbell P, Bareford D, Green AR, Harrison CN, et al. Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis. Br J Haematol. 2007; 138:821-2.1767288010.1111/j.1365-2141.2007.06741.xMcMullinMFReillyJTCampbellPBarefordDGreenARHarrisonCNet alAmendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosisBr J Haematol20071388212Search in Google Scholar
Passamonti F. How I treat polycythemia vera. Blood. 2012; 120:275-84.10.1182/blood-2012-02-36605422611155PassamontiFHow I treat polycythemia veraBlood201212027584Open DOISearch in Google Scholar
Silver RT, Chow W, Orazi A, Arles SP, Goldsmith SJ. Evaluation of WHO criteria for diagnosis of polycythemia vera@Colon@ a prospective analysis. Blood. 2013; 122:1881-6.10.1182/blood-2013-06-50841623900239SilverRTChowWOraziAArlesSPGoldsmithSJEvaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysisBlood201312218816Open DOISearch in Google Scholar
Roda P, Ferrari A, Tang X, Erlich P, Eisenhower C, Patel MD, et al. Determination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic scheme. Ann Hematol. 2014; 93: 1467-72.10.1007/s00277-014-2068-224687383RodaPFerrariATangXErlichPEisenhowerCPatelMDet alDetermination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic schemeAnn Hematol201493146772Open DOISearch in Google Scholar
Hsu HC. Pathogenetic role of JAK2 V617F mutation in chronic myeloproliferative disorders. J Chin Med Assoc. 2007; 70:89-93.1738915210.1016/S1726-4901(09)70337-5HsuHCPathogenetic role of JAK2 V617F mutation in chronic myeloproliferative disordersJ Chin Med Assoc2007708993Search in Google Scholar
Usman M, Bilwani F, Kakepoto GN, Adil SN, Sajid R, Khurshid M. Polycythemia vera and idiopathic erythrocytosis@Colon@ comparison of clinical and laboratory parameters. J Pak Med Assoc. 2004; 54:249-51.15270182UsmanMBilwaniFKakepotoGNAdilSNSajidRKhurshidMPolycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parametersJ Pak Med Assoc20045424951Search in Google Scholar
Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, et al. Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood. 2008 111: 1686-9.17984312PietraDLiSBrisciAPassamontiFRumiETheocharidesAet alSomatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disordersBlood20081111686910.1182/blood-2007-07-10157617984312Search in Google Scholar
Geetha JP, Arathi CA, Shalini M, Srinivasa Murthy AG. JAK2 negative polycythemia vera. J Lab Physicians. 2010; 2:114-6.10.4103/0974-2727.7221521346910GeethaJPArathiCAShaliniMSrinivasa MurthyAGJAK2 negative polycythemia veraJ Lab Physicians201021146304008821346910Open DOISearch in Google Scholar
